GO:0071354 cellular response to interleukin-6: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071354 describes the set of cellular changes triggered by interleukin-6 (IL-6), including altered gene expression, secretion, movement, and enzyme production.
• IL-6 activates JAK-STAT, MAPK, and PI3K-AKT signaling, leading to transcriptional programs that control inflammation, survival, and metabolism [1,4].
• The pathway is cell-type specific: in microglia-neural progenitor co-cultures, IL-6 reprograms transcriptional networks linked to neuroinflammation.
• IL-6 signaling intersects with autophagy and antioxidant responses, as shown in pancreatic beta cells where IL-6 reduces oxidative stress.
• Dysregulated cellular responses to IL-6 contribute to diseases such as hidradenitis suppurativa, lymphangioleiomyomatosis, and common variable immunodeficiency [4,5,7].
• CRISPR knockout, knock-in, and overexpression models enable causal testing of IL-6 pathway genes in relevant cell types [1,6].
Description
The Gene Ontology term GO:0071354, cellular response to interleukin-6, defines any process that changes a cell's state or activity in response to an interleukin-6 (IL-6) stimulus, encompassing movement, secretion, enzyme production, and gene expression. IL-6 is a pleiotropic cytokine that acts on diverse cell types, and its cellular response is central to inflammation, immune regulation, and tissue homeostasis [1,4]. Researchers study this term to understand how a single cytokine can elicit context-dependent outcomes, from protective antioxidant responses to pathogenic chronic inflammation [8,5]. The pathway is frequently dysregulated in human disease, making it a target for therapeutic intervention and a model for dissecting cytokine signaling [4,7]. This article integrates the QuickGO definition with published literature to provide a research-grade overview of the cellular response to IL-6, its molecular players, and experimental approaches for its study.
cellular response to interleukin-6 At A Glance
| GO ID | GO:0071354 |
|---|---|
| GO term | cellular response to interleukin-6 |
| Ontology | biological_process |
| Synonym | cellular response to IL-6 |
| Major function | Mediates changes in gene expression, secretion, movement, and enzyme activity in response to IL-6 |
| Cellular context | Occurs in immune cells, microglia, hepatocytes, beta cells, and other IL-6-responsive cell types |
| Key signaling modules | JAK-STAT, MAPK, PI3K-AKT, and autophagy-related pathways |
| Disease relevance | Inflammation, autoimmunity, metabolic stress, and tissue repair |
What Is GO:0071354?
GO:0071354 is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus. It is a biological process that captures the downstream cellular consequences of IL-6 receptor engagement, rather than the cytokine itself or its receptor alone.
Why Is cellular response to interleukin-6 Important in Cell Biology?
The cellular response to IL-6 is a fundamental mechanism by which cells adapt to inflammatory and metabolic challenges, and its dysregulation is implicated in a wide range of human diseases, from chronic inflammatory skin conditions to lung remodeling and immunodeficiency [5,4,7]. Understanding this process at the cellular level is essential for identifying therapeutic targets and for interpreting how genetic variants, such as those in the IL6 locus, affect disease susceptibility.
• IL-6 signaling controls acute-phase responses and immune cell activation.
• It regulates cell survival, proliferation, and differentiation in multiple tissues.
• The pathway modulates oxidative stress and autophagy in pancreatic beta cells.
• IL-6 responses are implicated in neuroinflammation and neural progenitor function.
• Genetic variants in IL6 affect hepatocyte responses to hypoxia/reoxygenation.
• Dysregulated IL-6 signaling contributes to hidradenitis suppurativa pathology.
• IL-6 is linked to B cell subtypes and vaccine responses in immunodeficiency.
• The pathway is a target for anti-inflammatory and anti-fibrotic therapies.
• Cellular responses to IL-6 vary by cell type and context, requiring model-specific study.
• CRISPR-based models enable precise dissection of IL-6 signaling components [1,6].
What Happens During cellular response to interleukin-6?
IL-6 receptor engagement and JAK activation
In simple terms: IL-6 binds to its receptor, which activates JAK kinases to start the signal.
The cellular response to IL-6 begins when IL-6 binds to the IL-6 receptor complex, leading to activation of Janus kinases (JAKs). This triggers phosphorylation of STAT transcription factors, which then translocate to the nucleus to alter gene expression. In microglia-neural progenitor co-cultures, IL-6 exposure induces rapid transcriptional changes consistent with JAK-STAT activation.
Transcriptional reprogramming
In simple terms: Activated STATs turn many genes on or off, changing the cell's behavior.
Activated STAT3 and other transcription factors drive a broad transcriptional program that includes inflammatory mediators, survival factors, and metabolic regulators [1,4]. In lymphangioleiomyomatosis models, mTOR dysregulation induces IL-6, which then acts in a paracrine manner to promote AT2 cell senescence and impede lung repair. This illustrates how the cellular response to IL-6 can propagate tissue-level dysfunction.
Crosstalk with autophagy and antioxidant responses
In simple terms: IL-6 can help cells handle stress by linking autophagy to antioxidant defenses.
In pancreatic beta cells, IL-6 reduces oxidative stress by linking autophagy with the antioxidant response, demonstrating a protective arm of the cellular response to IL-6. This crosstalk involves modulation of autophagy flux and upregulation of antioxidant enzymes, which may be relevant to metabolic diseases.
Cell-type specific outcomes
In simple terms: Different cells respond to IL-6 in different ways depending on their identity.
The cellular response to IL-6 is highly context-dependent. In hepatocytes, IL-6 and genetic variants at the rs1800796 locus influence responses to hypoxia/reoxygenation. In B cells from common variable immunodeficiency patients, IL-6 levels associate with B cell subtypes and vaccine responses. These examples highlight the need to study IL-6 responses in relevant cell models.
Feedback and regulation
In simple terms: The response is tuned by feedback loops that can amplify or dampen signaling.
The cellular response to IL-6 is regulated by negative feedback mechanisms, including SOCS proteins and phosphatases, which prevent excessive signaling. In hidradenitis suppurativa, the IL-1 pathway is hyperactive and contributes to skin infiltration and destruction, with IL-6 likely participating in the inflammatory milieu. Understanding these feedback loops is critical for therapeutic targeting.
Key Genes Involved in GO:0071354 cellular response to interleukin-6
The following genes and proteins are central to the cellular response to interleukin-6, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL6 | Encodes interleukin-6 cytokine | Ligand initiating the response; polymorphisms affect signaling |
| IL6R | IL-6 receptor subunit | Mediates ligand binding and JAK activation |
| JAK1 | Janus kinase 1 | Phosphorylates STATs downstream of IL-6R |
| JAK2 | Janus kinase 2 | Alternative JAK for IL-6 signaling |
| STAT3 | Signal transducer and activator of transcription 3 | Key transcription factor driving IL-6-responsive genes [1,4] |
| STAT1 | Signal transducer and activator of transcription 1 | Modulates inflammatory gene expression |
| SOCS3 | Suppressor of cytokine signaling 3 | Negative feedback regulator of IL-6 signaling |
| PIK3CA | PI3K catalytic subunit alpha | Activates AKT pathway downstream of IL-6 |
| AKT1 | AKT serine/threonine kinase 1 | Promotes survival and metabolic changes |
| MAPK1 | Mitogen-activated protein kinase 1 | ERK pathway component activated by IL-6 |
| MAPK3 | Mitogen-activated protein kinase 3 | ERK pathway component activated by IL-6 |
| MTOR | Mechanistic target of rapamycin kinase | Links IL-6 to senescence and lung repair |
| ATG5 | Autophagy related 5 | Autophagy machinery involved in IL-6-mediated antioxidant response |
| BECN1 | Beclin 1 | Autophagy regulator in IL-6 signaling |
| NFKB1 | Nuclear factor kappa B subunit 1 | Inflammatory transcription factor crosstalk |
| IL1B | Interleukin 1 beta | Inflammatory cytokine co-regulated with IL-6 |
| CD19 | CD19 molecule | B cell marker associated with IL-6 responses |
How Is cellular response to interleukin-6 Regulated?
The cellular response to IL-6 is tightly regulated by multiple mechanisms. Negative feedback via SOCS3 and other suppressors limits the duration and intensity of JAK-STAT signaling. In lymphangioleiomyomatosis, mTOR dysregulation induces IL-6, which then acts in a paracrine manner to promote AT2 cell senescence, illustrating how upstream metabolic pathways can regulate IL-6 production and response. Additionally, autophagy and antioxidant pathways intersect with IL-6 signaling in beta cells, providing another layer of regulation. These regulatory nodes are potential targets for modulating IL-6-driven pathologies.
cellular response to interleukin-6 and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL6 | Hidradenitis suppurativa | Keratinocyte knockout of IL6 or IL6R |
| MTOR | Lymphangioleiomyomatosis | TSC2-null cell models with IL6 knockout |
| IL6 | Pancreatic beta cell oxidative stress | Beta cell line with IL6 overexpression or knockout |
| IL6 | Common variable immunodeficiency | B cell co-culture with IL6 stimulation |
| IL6 | Hypoxia/reoxygenation in hepatocytes | Hepatocyte cell line with rs1800796 knock-in |
Inflammatory skin disease: hidradenitis suppurativa
In hidradenitis suppurativa, the IL-1 pathway is hyperactive and contributes to skin infiltration and destruction, with IL-6 likely participating in the inflammatory cascade. The cellular response to IL-6 in keratinocytes and immune cells may amplify tissue damage, making it a candidate for therapeutic intervention.
Lung disease: lymphangioleiomyomatosis
In lymphangioleiomyomatosis, mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence, impeding lung repair. This demonstrates how the cellular response to IL-6 can drive pathological remodeling in the lung.
Metabolic stress: pancreatic beta cells
IL-6 reduces beta-cell oxidative stress by linking autophagy with the antioxidant response, suggesting a protective role in diabetes. However, chronic IL-6 signaling may contribute to beta-cell dysfunction.
Immunodeficiency: common variable immunodeficiency
In common variable immunodeficiency, IL-6 levels associate with B cell subtypes and response to the Pneumovax-23 vaccine, indicating that the cellular response to IL-6 influences humoral immunity.
From cellular response to interleukin-6-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IL6 knockout alter inflammatory gene expression? | IL6 knockout in microglia or macrophages |
| How does a point mutation in IL6R affect JAK-STAT activation? | IL6R point-mutation knock-in cell lines |
| What is the effect of STAT3 gain-of-function? | STAT3 knock-in with activating mutation |
| Can tagged IL6 track secretion dynamics? | IL6 tagged knock-in with fluorescent protein |
| Does overexpression of IL6 induce senescence? | IL6 overexpression in AT2-like cells |
| How does IL6 variant affect hypoxia response? | rs1800796 knock-in in hepatocytes |
How to Study the cellular response to interleukin-6 Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Global gene expression after IL-6 stimulation |
| Phospho-STAT3 immunoblot | STAT3 activation | Validation of JAK-STAT signaling |
| LC3 flux assay | Autophagy activity | Assessing IL-6 effects on autophagy |
| ROS detection | Oxidative stress | Measuring antioxidant response |
| ELISA | Cytokine secretion | Quantifying IL-6 production |
| CRISPR knockout screen | Gene essentiality | Identifying regulators of IL-6 response |
| Flow cytometry | B cell subtypes | Linking IL-6 to immune cell populations |
Transcriptomic profiling
RNA-seq after IL-6 stimulation reveals the full transcriptional program of the cellular response, as demonstrated in microglia-neural progenitor co-cultures. This method identifies differentially expressed genes and pathways.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation downstream of IL-6, uncovering signaling nodes such as STAT3 and AKT.
Autophagy and oxidative stress assays
LC3 flux assays and ROS measurements can assess the link between IL-6, autophagy, and antioxidant responses in beta cells.
Functional genomics with CRISPR screens
CRISPR knockout libraries can identify genes that modify the cellular response to IL-6, enabling unbiased discovery of regulators.
How CRISPR Can Be Used to Study GO:0071354 cellular response to interleukin-6
Knockout
CRISPR knockout of IL6, IL6R, or STAT3 in relevant cell types can abolish the cellular response to IL-6, providing causal evidence for their roles. For example, IL6 knockout in microglia reduces inflammatory transcriptional programs.
Point Mutation
Introducing point mutations such as rs1800796 in the IL6 locus via CRISPR can test how genetic variants affect hepatocyte responses to hypoxia/reoxygenation. This approach links genotype to cellular phenotype.
Knock-in
Knock-in of tagged IL6 or IL6R allows real-time tracking of ligand-receptor dynamics and downstream signaling. This is useful for imaging and biochemical studies.
Overexpression
CRISPR activation or cDNA overexpression of IL6 can model chronic IL-6 signaling, as seen in lymphangioleiomyomatosis where mTOR dysregulation induces IL-6 and drives senescence.
How EDITGENE Supports cellular response to interleukin-6 Research
Researchers studying cellular response to interleukin-6-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activation. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for cellular response to interleukin-6 research.
Frequently Asked Questions About cellular response to interleukin-6
What is GO:0071354?
GO:0071354 is the Gene Ontology term for cellular response to interleukin-6, defined as any process that changes a cell's state or activity in response to an IL-6 stimulus.
What genes are involved in cellular response to interleukin-6?
Key genes include IL6, IL6R, JAK1, JAK2, STAT3, SOCS3, and MTOR, among others [1,4].
What diseases are associated with cellular response to interleukin-6?
Diseases include hidradenitis suppurativa, lymphangioleiomyomatosis, common variable immunodeficiency, and metabolic stress in beta cells [5,4,7,8].
How is cellular response to interleukin-6 studied?
It is studied using RNA-seq, phosphoproteomics, autophagy assays, and CRISPR screens in relevant cell models [1,8].
What is the role of IL-6 in microglia?
IL-6 induces transcriptional changes in microglia that are linked to neuroinflammation and neural progenitor function.
Can CRISPR be used to study IL-6 signaling?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal testing of IL-6 pathway genes [1,6].
What is the relationship between IL-6 and autophagy?
IL-6 can link autophagy with antioxidant responses to reduce oxidative stress in beta cells.
How does IL-6 contribute to lung disease?
In lymphangioleiomyomatosis, mTOR dysregulation induces IL-6, which promotes AT2 cell senescence and impedes lung repair.
What is the rs1800796 variant?
rs1800796 is a single nucleotide polymorphism in the IL6 locus that affects hepatocyte responses to hypoxia/reoxygenation.
What cell types respond to IL-6?
Many cell types respond, including microglia, hepatocytes, pancreatic beta cells, B cells, and keratinocytes [1,6,8,7,5].
Conclusion
The cellular response to interleukin-6 (GO:0071354) is a central biological process that integrates cytokine signaling with transcriptional, metabolic, and stress responses. Its dysregulation contributes to diverse diseases, and ongoing research using CRISPR and functional genomics continues to uncover new regulatory mechanisms. Understanding this pathway offers opportunities for therapeutic intervention in inflammation, autoimmunity, and tissue repair.
References
- 1. Couch ACM et al.. 2024. Transcriptional and cellular response of hiPSC-derived microglia-neural progenitor co-cultures exposed to IL-6.. Brain Behav Immun 122:27-43 PMID: 39098436
- 4. Babaei-Jadidi R et al.. 2025. mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis.. Nat Commun 16(1):8996 PMID: 41068078
- 5. Witte-Händel E et al.. 2019. The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction.. J Invest Dermatol 139(6):1294-1305 PMID: 30528824
- 6. Wang Z et al.. 2016. Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia/reoxygenation in hepatocytes.. Int J Mol Med 38(1):192-200 PMID: 27221654
- 7. Sharifi L et al.. 2019. Interleukin-1β and interleukin-6 in Common Variable Immunodeficiency and their association with subtypes of B cells and response to the Pneumovax-23 vaccine.. Eur Cytokine Netw 30(4):123-129 PMID: 32096473
- 8. Marasco MR et al.. 2018. Interleukin-6 Reduces β-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response.. Diabetes 67(8):1576-1588 PMID: 29784660
